Answers are grounded in this paper and cite their sources.
To the Editor: Sirolimus is a new, highly potent immunosuppressive drug1,2 that was recently licensed in the United States and is currently being evaluated in phase 3 clinical trials in Europe. The...
No takes yet. Share an insight, caveat, or question.
Morélon et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: